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Abstract
Tourette syndrome (TS) and other chronic tic disorders (CTD) are prevalent neurodevelopmental disorders, which can have a 
huge burden on families and society. Behavioral treatment is a first-line intervention for tic disorders. Despite demonstrated 
efficacy, tic reduction and utilization rates of behavioral treatment remain relatively low. Patient associations point to an 
urgent need for easy-to-undergo treatments that focus both on tic reduction and improvement of quality of life. To enhance 
treatment outcome and overcome treatment barriers, this pilot study’s aim was to investigate the feasibility and preliminary 
results of a brief, intensive group-based treatment. Tackle your Tics is a 4-day intensive and comprehensive group-based 
program for children and adolescents (9–17 years) with a tic disorder, consisting of exposure and response prevention (ERP) 
treatment and additional supporting components, such as coping strategies, relaxing activities and parent support. Assess-
ments were performed pre- and post-treatment and at 2 months follow-up, to test outcomes on tic severity and quality of 
life, and explore premonitory urges, emotional and behavioral functioning and treatment satisfaction (N = 14, of whom 13 
completed the treatment). Parents and children rated this treatment positive on a treatment satisfaction questionnaire. On 
tic severity (Yale Global Tic Severity Scale) and quality of life (Gilles de la Tourette Syndrome Quality of Life Scale for 
children and adolescents), improvements between pre-treatment and follow-up were found. Intensive ERP in group format 
is promising as a feasible treatment to improve both tic severity as well as quality of life. Larger controlled trials are needed 
to establish its effectiveness.
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Introduction
Tourette syndrome (TS) and other Chronic tic disorders 
(CTD) are characterized by the presence of sudden motor 
movements and/or vocalizations that persist for more than 
a year, frequently associated with comorbid problems (e.g., 
hyperactivity, compulsions) [1]. Tic disorders are prevalent 
disorders (0.77–1% for TS [2, 3]) and can have a serious, 
long-lasting impact on quality of life [4–7], daily function-
ing [5], emotional/behavioral problems [8, 9] and school 
results [10]. Moreover, tic disorders can lead to stress of 
children and families, stigmatization [11], an elevated risk 
for suicide [12] and costs for society [4]. Tic severity alone 
does not define individual impairment or quality of life [7, 
13]. Patient organizations emphasize the need for effective 
and available treatments, that not only focus on tic reduc-
tion but also on enhancing quality of life [14].
Behavioral treatment for tics is recommended as first-line 
intervention according to European clinical guidelines [15]. 
Several behavioral treatments for tics have been developed, 
specifically habit reversal (HR), Comprehensive Behavioral 
Intervention for Tics (CBIT) and exposure and response 
prevention (ERP). Research into behavioral treatment for 
tics report moderate-to-high effect sizes (0.57–1.5), but tic 
reductions remain relatively low (on average 30% on the 
Yale Global Tic Severity Scale, YGTSS) [16]. Research 
on ERP, however, is promising but limited. A compara-
tive study of ERP versus HR showed that both treatments 
resulted in significant tic reduction with no difference 
between the two treatment conditions [17].
In addition, utilization rates for evidence-based behav-
ioral therapies remain low [18, 19]. The lack of locally 
available trained therapists is a common treatment barrier. 
Families often have to travel far and as a consequence of 
low access, many children receive pharmacological treat-
ment, despite a preference for behavioral treatments (C. 
Verdellen, J. Van de Griendt, N. Van de Berg, and S. Van 
Vugt; Dutch Tourette patients do not receive the treatment 
they prefer: data presented at the Tourettes association 
annual patients day 2014). Online behavioral treatment 
is increasingly being offered and investigated to solve the 
lack of specialized therapists, but offers few opportunities 
for peer and parent support and meetings.
Recently, two case studies in the USA and UK have 
suggested that brief, intensive forms of behavioral therapy 
for TS (which provided techniques as CBIT [20], ERP 
[21]) are as effective as weekly therapy sessions over a 
longer time frame. That is, in a clinical replication series 
of intensive CBIT (N = 5; [20]), an average decrease on 
the YGTSS total tic score of 28% was found in responders. 
Significant reductions of tic severity and improvements 
on daily functioning, quality of life, and emotional and 
behavioral difficulties were found after intensive ERP 
for children (provided in 2 consecutive days followed by 
weekly remote delivery by telemedicine) [21]. Besides, 
promising treatment outcomes have been found for an 
intensive ERP-based therapy for children with obses-
sive–compulsive disorder (OCD) [22–24]. Also, in other 
patient populations (e.g., adolescents with post-traumatic 
stress disorder, PTSD, receiving intensive ERP [25]), 
intensive forms of behavioral treatment have been suc-
cessful. Moreover, research in anxiety disorders showed 
that treatment success may even be larger using intensive 
brief treatments compared to traditional approaches [26].
In addition, promising treatment outcomes have been found 
for an intensive outpatient group therapy (HRT) [27, 28] and 
in comprehensive CBIT-therapy that also focusses on second-
ary outcomes [7] in children with tic disorders. Benefits of 
group-based treatments may be peer support, reduced wait-
ing lists, and increased cost-effectiveness. Nissen et al. com-
pared combined HRT and ERP in a group setting versus in an 
individual setting and found no significant difference in total 
tic scores [40]. Himle examined group CBT for tic-related 
and non-tic-related OCD, showing that the treatment reduced 
OCD symptoms in both groups [29]. This indicates a possible 
improvement of comorbid symptoms in group therapy.
At present, there is a lack knowledge on the feasibility of 
an intensive form of behavioral treatment for tic disorders. 
Therefore, we developed a brief, intensive and comprehen-
sive group-based ERP treatment program for children with 
tic disorders, Tackle your Tics. The aims of this pilot study 
were (1) to study the feasibility of Tackle your Tics and (2) 
to study treatment outcomes regarding tic severity (primary 
outcome), quality of life, premonitory urges and emotional/
behavioral problems. We hypothesized that Tackle your Tics 
is a feasible treatment program for youths with TD. Fur-
thermore, we expected to find indications of improvements 
in treatment outcomes. Importantly, we expect that Tackle 
your Tics has an additional surplus value in creating oppor-
tunities to train more behavioral therapists, in the specific 
tic-ERP techniques by experts in this field, since they can be 
co-therapists during this treatment. Increasing the number 
of trained therapists will lead to reduced treatment barriers.
Methods
Design
The present study is a pilot study, based on a small patient 
sample (N = 14) of children aged 9–14 years of age. Repre-
sentatives of the Dutch national patient organization (among 
which author LPLB) were actively involved in this project, 
from start to finish, including developing the design of the 
study. This included continuous reviewing of the research 
process and the content of the project from the patients’ 
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perspective by ‘experts by experience’, developing and per-
forming workshops on coping strategies and parent support 
meetings during the treatment. Patients and their parents 
were recruited between June 2018 and December 2018 by 
the Dutch Tourette Association and the outpatient clinic De 
Bascule in Amsterdam. Tic severity and other inclusion and 
exclusion criteria were determined by an experienced child 
psychiatrist.
Inclusion criteria were: (a) youths aged 9–17 years, (b) 
diagnosed with TS or CTD, using diagnostic criteria of the 
Diagnostic and Statistical Manual of Mental Disorders, 5th 
edition [30], (c) with at least moderate tic severity as indi-
cated by a YGTSS total score > 13 (or > 9 for children with 
motor or vocal tics only).
Exclusion criteria were: (a) behavioral treatment for tics 
in the past 12 months, (b) pharmacological treatment for 
tics that has not been stable the for the past 6 weeks or with 
planned changes during study participation, (c) poor mas-
tery of the Dutch language, (d) IQ < 75, (e) serious physical 
disease, (f) substance abuse, (g) suicidality, (h) psychotic 
disorders, (i) severe autism spectrum disorders (ASD) or 
attention deficit hyperactivity disorder (ADHD) problems, 
which would hamper group functioning, (j) poor group func-
tioning, as reported by child and/or parents during intake. 
Since TS  is seldom seen without comorbidities [1], co-
occurring ADHD, OCD, other anxiety disorders or mood 
disorders were included, unless the disorder required imme-
diate treatment or change in current treatment.
Before the start of the therapy weeks, four co-therapists 
(psychologists with 2.5–5 years of experience) were trained 
by experts in behavioral therapy (ERP) for tic disorders. A 
patient advisory board, with parents and young adult patients, 
that gave feedback on the project, was installed during the 
study preparation phase and before treatment. Based on this 
feedback, some adaptations were applied to the program and 
data gathering. That is, we took into account their advice to 
guard against possible unrealistic expectations of the treat-
ment outcomes (such as a complete disappearance of the tics) 
and possible misunderstanding of psycho-education, and to 
check the need for more care or support after the program, 
and the need for more tools to exercise at home. Therefore, 
we clarified the psycho-education for parents and added ques-
tions to the treatment satisfaction questionnaires. Also, the 
advisory board strongly recommended to build a positive and 
safe group atmosphere from the start, without children having 
to answer difficult questions about their problems. Therefore, 
we decided to collect the outcome measures at home, instead 
of during the treatment program at the outpatient clinic.
The children participated in one of two outpatient groups at 
De Bascule, Academic Centre for Child and Adolescent Psy-
chiatry in Amsterdam, in September 2018 and February 2019, 
including, respectively, 6 and 8 children per group. Ther-
apy sessions and psycho-education group meetings were 
performed by three highly experienced behavioral therapists, 
who are experts on tic disorders and ERP, assisted by three co-
therapists, for training purposes. Coping workshops and par-
ent meetings were developed and performed by experienced 
patient representatives of the Dutch Tourette Association.
Intervention
Tackle your Tics is a group therapy program based on evi-
dence-based ERP [31]. ERP aims to interrupt a postulated 
cycle of negative reinforcement between a premonitory urge 
and a subsequent tic by learning patients to tolerate pre-
monitory urges while suppressing tics for prolonged time 
periods [17, 32]. To optimize exposure, urges are provoked, 
for instance by asking the patient to imagine situations with 
many tics, talking about tics and introducing urge-eliciting 
objects (e.g., exciting games). The therapist functions as a 
coach, encouraging the patient to improve his/her achieve-
ments. ERP usually consists of 12 weekly individual sessions 
(12 × 45 ERP-minutes = 540 min). In the Tackle your Tics pro-
gram, ERP is provided in a brief, intensive format of 4 days: 3 
consecutive days and 1 booster day after a week (4 × 135 ERP 
minutes = 540 min, see Table 1). The program was offered 
in groups of 6–8 children, to facilitate motivation and peer 
support. Apart from the overall group format, during Tackle 
your Tics, ERP exercises were trained in smaller subgroups of 
2–3 children, in which children assisted each other (by timing, 
registering tics and encouraging). When needed, a child could 
train a specific exercise for a while individually with a thera-
pist. On day 3, children went outside of the treatment center 
(e.g., riding a bike, being among other people, playing games) 
with the therapists to learn to generalize their newly learned 
skills. Also, several supporting and motivating activities were 
added to enhance motivation and fun, and reduce drop out.
Coping strategy workshops
Daily coping strategy workshops were given by trained 
young adult patients (experts-by-experience who are also 
educational professionals) from the national patient associa-
tion. They taught the children how to cope with their symp-
toms in a positive ‘mind-set’. In accordance with a large 
European patient survey [14], this support did not focus on 
tics only but also on other symptoms, comorbidities and 
positive characteristics and strengths.
BT‑Coach
BT-Coach is a mobile application that helps children to prac-
tice the ERP exercises, learned in the therapy sessions, in 
the absence of a therapist [33]. Through audio feedback, 
the app takes over the coaching role of the therapist dur-
ing homework exercises. When a tic is expressed, the child 
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registers this by pressing ‘Tap for a Tic’. BT-Coach stimu-
lates the child to stop the next tic and work on new records. 
An improved version is currently being developed, in which 
data collection is optimized and calculations are possible. 
In this study, the BT-Coach was introduced during the first 
training days and sometimes used in the therapy sessions 
when children liked this. The app was used to motivate the 
children to continue with the exercises at home. On the third 
and fourth training day, the app was used as part of a relapse 
prevention plan (‘keep the tics away plan’). No data were 
collected for this study or in medical files.
Parent meetings
Parent meetings were in part attended by a therapist who 
explained the ERP treatment, discussed expectations and 
how parents could help their child gaining control over the 
tics during and after treatment. In addition, an experienced 
parent counsellor of the patient association offered parents 
the opportunity to exchange experiences in the parent group 
and find emotional support. At the end of each day, thera-
pists had short individual meetings with the child and its par-
ents to evaluate the day and ERP exercises, give advices on 
how to handle tics at home and answer possible questions.
Psycho‑education
Children as well as their parents learned about premonitory 
sensations (‘tic alarms’), tic triggers, difficult moments and 
practicing at home.
Relaxation
The Tackle your Tics program contained several short relax-
ation trainings, focusing on breathing techniques, as well as 
playtime and fun activities.
Measurements
Assessments were performed pre-treatment (T0, 1 week 
before treatment) and post-treatment (T1, 1 week after treat-
ment: (that is: a week after the ‘booster’ day, to be able to 
measure the preceding week’s tic severity, after the booster 
session, by the YGTSS) and at the follow-up assessment 
(T2, 2 months after treatment).
Demographic variables/patient characteristics (gen-
der, age, cultural background, parents’ educational level, 
comorbidities) were derived from medical files and a semi-
structured interview (Anxiety Disorder Interview Sched-
ule; ADIS, parent version) [34].
Feasibility was  assessed by: (1) attendance/drop-out 
rates, (2) standardized treatment satisfaction forms (parent 
and child version, with a rating on five-point Likert scale, 
ranging from 1 = very negative/not helpful at all to 5 = very 
positive/helpful and also by questions in open format), spe-
cifically designed for this study, to measure satisfaction 
about the treatment program as a whole, the program com-
ponents and individual experiences or recommendations, (3) 
interviews/evaluations with the patient advisory board and 
caregivers, to understand the needs and concerns of partici-
pating parents and children.
Tic severity (key outcome) was assessed by the semi-
structured interview Yale Global Tic Severity Scale; YGTSS 
[35]. The global score (response range 0–100) is com-
posed of an impairment score (0–50) and a total tic score 
(0–50). The total tic score, used as our primary outcome, 
adds the total motor tic score (0–25) to the total vocal tic 
score (0–25). We defined a 25% tic reduction as a positive 
response [36].
Quality of life was measured by the Gilles de la Tourette 
Syndrome Quality of Life Scale for children and adolescents; 
C&A-GTS-QOL [37], which is a 27-item disorder-specific 
patient-reported scale for the measurement of health-related 
quality of life in patients with TS (range 27–135).
Premonitory urges were assessed by the Premonitory 
Urges for Tics Scale; PUTS [38]. This is a nine-item self-
report questionnaire which assesses tic-related feelings and 
sensations (premonitory urges) (range 9–36).
Emotional/behavioral functioning was measured by the 
Child Behavior Checklist; CBCL [39, 40]. This 113-item par-
ent-report questionnaire assesses emotional and behavioral 
problems, covering 8 dimensions (raw scores were analyzed).
Statistical analyses
To avoid chance findings, only the key outcome (tic severity) 
and our main secondary outcome (quality of life) were sta-
tistically tested. Other measurement outcomes were reported 
descriptively. To test whether there were changes in the main 
outcomes scores, from pre- to post-assessment to follow-up, 
repeated-measures ANOVAs were performed on the key out-
come (tic severity) and our main secondary outcome (quality 
of life). The effect sizes were calculated in SPSS as Partial 
Eta Squared. A nonparametric test (related-samples Fried-
man’s two-way analyses of variance by ranks) was used as 
an extra control. If the parametric test and the nonparametric 
test lead to the same conclusion, any violations of assump-
tions apparently have little influence or are absent.
For each variable, complete case analysis was performed, 
to avoid imputation of missing data. A p value of < 0.05 
was considered significant. To test for multiple compari-
sons, we did a Bonferroni correction (p < 0.025). SPSS 
Version 25 was used for the analyses (IBM SPSS Statistics 
for Windows, Version 25.0. Armonk, NY: IBM Corp). As 
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a sensitivity analysis, we reanalyzed our data with includ-
ing the patient who was excluded because of poor group 
functioning.
Results
Patient characteristics
A total of 27 families were interested in participating, of 
which 14 children were included. The 13 excluded children 
did not meet the criteria concerning age (4; 2 < 9 years, 
2 > 17 years), tic severity (1; very mild tics), had received 
behavioral therapy for tics in the previous 12 months (2) or 
lacked motivation (2). Other reasons were: no availability 
left in the last group (2) and living abroad (1). However, 
from the eligible children who met the inclusion criteria, 
only one finally did not participate since the timing of the 
groups conflicted with school activities. Therefore, 14 
patients (aged 9–14 years) diagnosed with Tourette Syn-
drome (TS) were included. One included patient dropped 
out due to poor group functioning (which was not identified 
during intake). A total of 13 included patients completed 
the full therapy program. Table 2 shows the main patient 
characteristics. Percentages of comorbid ASD and anxiety 
disorders were > 35%. Parents with a high level of education 
were overrepresented (57.9%).
Feasibility
In the first therapy group, one boy with TS and ASD dropped 
out at the end of day 1 because of poor group functioning and 
lack of cooperation. There were no drop-outs in the second 
group. Both (remaining) group sizes (5 and 8) were feasible 
according to evaluations with the team members (behavioral 
therapists and patient experts). Performing the program with 
three therapists and eight patients offers sufficient space for 
an alternative program layout in parallel sessions or for extra 
attention in response to unexpected problems. Our team of 
clinicians estimated that such temporary individual moments 
were needed for 25% of the participating children and offered 
possibilities for personalizing the therapy.
Overall, parents and children reported to be satisfied about 
this treatment program (see appendix 1). On the treatment 
satisfaction questionnaires (parent and child version), the 
mean score was almost 4 at the five-point scale questions 
(mean 3.94 for children, 3.92 for parents). Children as well 
as parents would recommend this treatment to other families 
Table 2  Main demographic 
characteristics and 
comorbidities, from diagnostic 
intake and medical files (N = 14)
SD standard deviation, ADHD attention deficit hyperactivity disorder, ASD autism spectrum disorder, OCD 
obsessive–compulsive disorder
Demographic characteristics Group 1 (N = 6) Group 2 (N = 8) Total %
Age (years), mean 12.13 (range 
9.03–14.81, 
SD ± 1.93)
11.36 (range 
9.36–13.74, 
SD ± 1.55)
11.69 (range 
9.03–14.81, 
SD ± 1.70)
Gender
 Male 4 6 10 71.4
 Female 2 2 4 28.6
Cultural background
 Dutch 6 8 14 100
Parents education level
 Low (0–3) 1 0 1 5.3
 Middle (4–7) 2 5 7 36.8
 High (8–9) 4 7 11 57.9
Comorbidities
 ADHD 3 0 3 21.4
 ASD 1 4 5 35.7
 OCD 0 0 0 0
 Anxiety 1 4 5 35.7
Medication for tics or comorbidities
 Aripiprazol 1 2 3 21.4
 Clonidine 0 1 1 7.1
 Risperidon 0 1 1 7.1
 Citalopram 0 1 1 7.1
 Methylphenidate 1 0 1 7.1
 Haloperidol 1 0 1 7.1
European Child & Adolescent Psychiatry 
1 3
(mean score 4.77 for children, 4.23 for parents). Scores 
for the rating of different program components were posi-
tive regarding the ERP-sessions, psycho-education, coping 
strategy workshops, the ERP training app (BT-Coach) and 
parent meetings, and neutral on relaxation exercises. Other 
(open) questions asked for explanations, suggestions and 
remarks. Several children and parents reported the children 
learned a lot, had fun and felt supported. Both children and 
parents mentioned the time for lunchbreaks and playtime was 
experienced as somewhat short. Parents also reported they 
experienced recognition, education and support themselves. 
They described in what way they thought the program was 
helpful for their child (e.g., having a sense of control over the 
tics (84.6%); contact with other children with tics (38.5%)). 
These findings were used to evaluate the need for adaptations 
for future implementation of the Tackle your Tics program.
Tic severity
Main treatment outcomes are shown in Table 3. The pri-
mary outcome, the mean total tic score (as measured by the 
YGTSS) decreased from a means of 27.08 at baseline with 
4.23 points (16%) to follow-up: 3.39 points from pre- to 
post-treatment (23.69) and another 0.84 points to follow-up 
(22.85). 23.1% of the participants were rated as responders 
from T0 (pre-treatment) to T1 (post-treatment) and 53.8% as 
responders from T0 (pre-treatment) to T2 (follow-up) (data 
not shown in the table)]. Repeated measures analysis of vari-
ance (ANOVA) showed that the decrease on the YGTSS 
total tic score was significant (p = 0.013, effect size = 0.412). 
A nonparametric test (related-samples Friedman’s two-way 
analysis of variance by ranks), executed as an extra control 
test, was performed and also showed a decrease of the total 
tic score (p = 0.050). Figure 1 shows the total tic scores of 
treatment completers (n = 13). As a sensitivity analysis, we 
reanalyzed our data with including the complete YGTSS 
data (T0, T1, T2) of the patient who dropped out because of 
poor group functioning (n = 14). This analysis also showed 
a significant decrease (p = 0.006, effect size = 0.454, non-
parametric test p = 0.026). Therefore, our conclusion did 
not depend on the inclusion of exclusion of the participant, 
which adds to the robustness of our inferences. 
The mean score for motor tics decreased with 3.46 points 
(22%) from baseline to follow-up. Vocal tics decreased with 
0.77 points (7%) from baseline to follow-up. Functional 
impairment (as measured by the YGTSS) decreased with 
7.7 points (31%) from baseline to follow-up.
Quality of life
Overall, the scores of this sample on a quality of life ques-
tionnaire (C&A-GTS-QOL total problem score) improved 
significantly, with 14% from pre- to post-treatment and 20% 
from pre-treatment to follow-up (p = 0.002, using repeated 
measures analysis of variance, ANOVA, effect size = 0.584). 
A nonparametric test (related-samples Friedman’s two-way 
analysis of variance by ranks), performed as an extra control 
test, also showed a significant decrease of the total problem 
score (p = 0.002). As a sensitivity analysis, we reanalyzed 
our data for quality of life with including the patient who 
dropped out because of poor group functioning (n = 13), 
imputing missing data from T1 and T2 for this patient (based 
on the baseline measurement on T0). This analysis also 
showed a significant decrease (p = 0.003, effect size = 0.539, 
nonparametric test p = 0.002). Therefore, our conclusion did 
not depend on the inclusion of exclusion of the participant, 
which adds to the robustness of our inferences.
Other secondary outcomes
Descriptively statistic showed premonitory urges scores 
decreased with 3%, which is in line with previous studies in 
which premonitory urges showed no difference from pre- to 
post-treatment (e.g., [41]). Behavioral and emotional prob-
lems, as measured by the Child Behavioral Checklist (CBCL) 
decreased with 37% between pre-treatment and follow-up. 
Due to technical (online) problems, data on behavioral/emo-
tional problems were complete for only nine children.
Group, gender and age differences
As can be seen in appendix 2, children in the second group, 
girls and older children showed more improvement.
Discussion
This study shows promising results regarding the feasibility 
of intensive ERP therapy as offered in the Tackle your Tics 
program. In line with our hypotheses, the treatment program 
was feasible and satisfactory for participating children and 
their families. The results on treatment outcome show indi-
cations of effectiveness of the program, to improve both tic 
severity and quality of life.
Despite these promising improvements on tic severity and 
quality of life, mean total tic scores decreased only 16% from 
pre-treatment to follow-up in this study. Impairment scores 
improved 41% pre- to post-treatment (31% pre-treatment 
to follow-up). In previous studies on behavioral therapy 
for tics, these percentages were higher. In a meta-analysis 
by McGuire et al. [16], YGTSS total tic scores decreased 
around 30% in most studies. A study of an individual, 
weekly treatment program ‘Living With Tics’ [7], aimed to 
reduce impairment and improve quality of life, found a total 
 European Child & Adolescent Psychiatry
1 3
Ta
bl
e 
3 
 M
ain
 tr
ea
tm
en
t o
ut
co
m
es
 of
 tr
ea
tm
en
t c
om
pl
ete
rs 
on
 T
0 (
pr
e-
tre
atm
en
t),
 T
1 (
po
st-
tre
atm
en
t) 
an
d T
2 (
2 m
on
th
s f
ol
lo
w-
up
) (
co
m
pl
ete
 ca
se
s)
95
%
 C
I 9
5%
 co
nfi
de
nc
e i
nt
er
va
l f
or
 m
ea
n, 
YG
TS
S 
Ya
le 
Gl
ob
al 
Ti
c S
ev
er
ity
 S
ca
le,
 P
U
TS
 P
re
m
on
ito
ry
 U
rg
e f
or
 T
ics
 S
ca
le,
 C
&
A-
G
TS
-Q
O
L 
Th
e G
ill
es
 D
e L
a T
ou
re
tte
 S
yn
dr
om
e-
Qu
ali
ty
 o
f L
ife
 
Sc
ale
 fo
r C
hi
ld
re
n a
nd
 A
do
les
ce
nt
s, 
C
BC
L 
Ch
ild
re
n B
eh
av
io
r C
he
ck
lis
t
T0
T1
T2
M
ea
n
Ra
ng
e
95
% 
CI
SD
M
ea
n
Ra
ng
e
95
% 
CI
SD
M
ea
n
Ra
ng
e
95
% 
CI
SD
To
tal
 ti
c s
co
re
(Y
GT
SS
 to
tal
 (m
ot
or
ic 
+ 
vo
ca
l) 
tic
 sc
or
e, 
n =
 13
)
27
.08
16
–3
5
23
.12
–3
1.0
4
6.5
51
23
.69
8–
35
18
.69
–2
8.6
9
8.2
70
22
.85
11
–3
0
19
.33
–2
6.3
6
5.8
14
M
ot
or
 ti
cs
(Y
GT
SS
 to
tal
 m
ot
or
 ti
c s
co
re
, n
 =
 13
)
15
.92
10
–2
0
13
.85
–1
7.9
9
3.4
27
13
.46
0–
20
10
.40
–1
6.5
2
5.0
60
12
.46
6–
17
7.1
4–
13
.63
3.0
72
Vo
ca
l t
ics
(Y
GT
SS
 to
tal
 vo
ca
l t
ic 
sc
or
e, 
n =
 13
)
11
.15
0–
19
7.7
1–
14
.60
5.6
99
10
.23
0–
18
18
.69
–2
8.6
9
5.7
03
10
.38
0–
19
19
.33
–2
6.3
6
5.3
63
Im
pa
irm
en
t
(Y
GT
SS
 im
pa
irm
en
t s
co
re
, n
 =
 13
)
24
.62
10
–4
0
18
.27
–3
0.9
6
10
.50
0
14
.62
0–
30
7.8
1–
21
.42
11
.26
6
16
.92
0–
40
9.3
7–
24
.48
12
.50
6
Gl
ob
al 
tic
 se
ve
rit
y
(Y
GT
SS
 gl
ob
al 
tic
 se
ve
rit
y s
co
re
, n
 =
 13
)
51
.69
36
–7
4
44
.19
–5
9.1
9
12
.41
2
38
.31
18
–6
5
28
.69
–4
7.9
3
15
.91
8
39
.77
11
–6
8
30
.29
–4
9.2
4
15
.68
0
Qu
ali
ty
 of
 li
fe
(C
&
A-
GT
S-
QO
L 
to
tal
 pr
ob
lem
 sc
or
e, 
n =
 12
)
58
.92
30
–9
2
45
.08
–7
2.7
5
21
.78
50
.42
28
–8
8
38
.59
–6
2.2
5
18
.62
47
.00
31
–8
3
35
.24
–5
8.7
6
18
.51
Pr
em
on
ito
ry
 ur
ge
s
(P
UT
S 
to
tal
 sc
or
e, 
n =
 12
)
21
.17
15
–3
2
18
.20
–2
4.1
3
4.6
7
20
.58
9–
28
16
.91
–2
4.2
5
5.7
8
20
.58
11
–3
1
16
.69
–2
4.4
8
6.1
3
Be
ha
vi
or
al 
pr
ob
lem
s
(C
BC
L 
to
tal
 sc
or
e, 
n =
 9)
45
.11
7–
91
23
.09
–6
7.1
3
28
.64
63
39
.55
6
5–
96
16
.48
–6
2.6
3
30
.02
13
28
.56
4–
59
12
.20
–4
4.9
1
21
.27
86
Tr
ea
tm
en
t s
ati
sfa
cti
on
 (c
hi
ld
re
n f
or
m
s, 
n =
 13
)
3.9
43
3.2
7–
4.9
1
3.6
7–
4.2
2
0.4
56
28
Tr
ea
tm
en
t s
ati
sfa
cti
on
 (p
ar
en
t f
or
m
s, 
n =
 13
)
3.9
16
2.4
8–
4.6
4
3.5
7–
4.2
5
0.5
59
26
European Child & Adolescent Psychiatry 
1 3
tic reduction of 30% and a reduction of 70% in impairment 
score (as measured by the YGTSS).
Improvement of quality of life (13% measured by the Ped-
sQL, Pediatric Quality of Life Inventory) was comparable 
with the results of our Tackle your Tics study (14% pre- to 
post-treatment, 20% to follow-up).
There are several explanations for these findings. First, 
Blount et al. [20] suggested that patients who receive inten-
sive treatment may not have the opportunity to practice their 
newly acquired skills within their normal environment until 
after treatment is complete. Possibly, children in our Tackle 
your Tics study did improve quickly but did fewer exercises 
during and after the treatment period. Since post-treatment 
measurements were performed a week after the last treat-
ment day (to be able to measure the last week’s tic severity 
by the YGTSS), these improvements may not (yet) have been 
generalized to the home environment. We expected that chil-
dren and parents would have more time and motivation to 
practice at home between post-treatment measurement and 
follow-up. At follow-up, only seven children (54%) reported 
that they continued doing ERP exercises after the treatment 
days on a regular basis. Of these children, 6 were responders 
with over 25% total tic reduction from pre-treatment to fol-
low-up. The low rate of children who reported to have prac-
ticed at home can be explained by the following possibilities: 
(1) parents did receive education about the therapy but no 
hands-on training; therefore, parents may not have helped 
their children sufficiently with the exercises; (2) children 
learned to accept their tics in the coping strategy workshops, 
which may have reduced the need to exercise and reduce 
their tics. In a get together meeting with participating par-
ents and children (after completion of all treatments and 
measurements), several parents reported their children felt 
no necessity or obligation towards a therapist anymore, after 
the treatment was finished. Based on this feedback and the 
findings from the treatment satisfaction questionnaire, we 
recommend to add the following elements in future use of 
the Tackle your Tics program: (1) parent involvement during 
therapy sessions, to train parents how to help their children 
during home exercises, and (2) an extra booster afternoon 
after 1 month, to keep the children motivated to practice at 
home. Finally, some parents and children stated they now 
felt more in control of tics and did not feel the necessity to 
continue exercising all the time, since they now know how 
to reduce tics in time of stress and when they wanted to.
However, previous studies [16, 22] found that intensive 
individual treatment lead to improvement comparable to care 
as usual (weekly individual therapy sessions). In studies on 
intensive behavioral therapies for children with anxiety disor-
ders or OCD, it has been suggested that condensing the spac-
ing of sessions can optimize conditions for reducing symp-
toms, by maximizing (extinction) learning by massed practice, 
increased family’s attention on treatment, faster reduction of 
functional impairment and better therapists’ monitoring of 
adherence [24, 26, 43]. The intensive format also facilitates 
patients to dedicate time specifically to detecting urges and 
tics and implement their treatment exercises without the dis-
tractions of day-to-day life [44]. Our clinical impression of 
Fig. 1  Box and whisker plot 
of total tic scores of treat-
ment completers (n = 13) on 
the YGTSS at pre-treatment 
(T0), post-treatment (T1), and 
follow-up (T2). The dots show 
individual scores, the vertical 
lines (whiskers) show the ranges 
of scores, and the boxes show 
the first quartile to the third 
quartile with a line through the 
center at the median
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the team was that progress in therapy sessions seemed to be 
achieved very quickly in both groups, although not formally 
measured with (intermediate) measurements during therapy. 
After the first day, several disturbing tics (e.g. eye rolling, 
face rubbing) were already tackled in some children. On day 
3, children went outside of the treatment center (e.g., riding 
a bike, being among other people, playing games) with the 
therapists to learn to generalize their newly learned skills. The 
small decrease in vocal tics (7%) may be explained by the 
fact that therapists focused on the tics that were most present 
and distressing to the child. These tics were mostly motoric 
tics that impaired concentration and activities or were painful.
Second, the group setting may have influenced the treat-
ment outcome. The therapy sessions were partly in small 
groups of 2 or 3 children, who may have had less individual 
practice while supporting other children. Nissen et al. [41] 
compared behavioral treatments for tics (habit reversal 
training and ERP) in a group setting to individual training, 
and found no significant differences in total tic scores, but 
individual training showed significantly greater reduction 
in the functional impairment score and negative thoughts 
and interpretations of their tics. They suggest that in an 
individual setting, the interaction between therapist and 
the child is more direct, and the therapist is able to focus 
more intensely on a particular child’s resources and difficul-
ties. Also, group processes may have influenced the treat-
ment outcome. As can be seen in Table 2, the children with 
comorbid ASD and anxiety disorders were mainly in the 
same group (group 2, N = 8). Our clinical impression was 
that this group provided a safe and quiet environment, in 
which children may have benefited more from the program 
than children in the first group (group 1, N = 6). In group 
1, ADHD symptoms were more prominent (50%) and the 
group—although smaller—was described by the therapists 
and patient representatives as more restless (although group 
dynamics were also positive and supportive). Appendix 2 
shows that treatment outcomes of group 2 improved more, 
which may be an indication of difference in the group par-
ticipants. However, previous studies [27, 41, 45] suggest 
that group therapy for children with tics appeared feasible 
and has comparable treatment outcomes as individual ther-
apy. Being around other children with tics did not increase 
tic expression. Moreover, benefits of group-based treat-
ment studies have been reported: reducing waiting lists, 
increasing the cost-effectiveness and providing peer support 
and a safe space for sharing experiences (S. Zimmerman 
et al. Comprehensive Behavioral Intervention for Tics vs 
Psychoeducational-Supportive treatments in group setting 
for children with chronic tic disorders: A randomized con-
trolled trial. Oral presentation at the European Conference 
on Tourette Syndrome and Tic Disorders 2018).
Both parents and children reported a wide range of scores 
(1–5) in the treatment satisfaction forms on the question “Have 
your/your child’s tics been reduced?” at post-treatment. One 
parent and one child did not experience any reduction. Interest-
ingly, parents and children responded positively on the question: 
“How helpful was this therapy week for you/your child’s prob-
lems?” Most of them mentioned that having a sense of control 
over the tics and to be able to suppress them temporarily, was 
helpful (84.6%) which was also found in the study of Nissen 
et al. [41] in group settings as well as individual settings. Also, 
many parents reported that the contact with other children with 
tics and being not the only one with tics, was helpful (38.5%).
This study is, to our knowledge, the first study worldwide 
into a brief, intensive group-based exposure therapy for 
children with chronic tic disorders. Considering the prom-
ising outcomes, we recommend to study the effectiveness 
in larger trials. If this type of treatment is shown effective, 
this program can offer several benefits. It can expand the 
access to behavioral treatment for children and adults living 
in different areas, without local specialized therapist trained 
in treatment of tics. Families find it easier to travel for a 
consecutive series of days (or possibly stay overnight) than 
to travel for a longer period for weekly individual sessions. 
Furthermore, an advantage is that brief intensive therapy 
can bring improvements in daily functioning in a much 
shorter time period, so that children can benefit earlier. In 
this shorter period of time, different supporting components 
can be offered simultaneously, among which coping strategy 
workshops and parent meetings organized by the patient 
organization. The treatment program offers opportunities 
to educate behavioral therapists in exposure and response 
prevention therapy for tics. When future research shows 
which children benefit most from this intensive group-based 
format and for which children individual care as usual in 12 
weekly sessions is recommended, this knowledge will offer 
opportunities to personalize treatment advice in the future.
Strengths and limitations
Although our results are promising, we have to keep in mind 
several limitations of this study. The sample size was small 
(N = 14) with no control group for the natural course of tics 
and other symptoms. An alternative would have been to 
assess a baseline phase and to compare the baseline phase 
with the treatment phase (e.g., Viefhaus et al. [46]). Since 
there was only one treatment condition, the YGTSS interview 
could not be rated blinded. No objective measurement of tic 
severity like video rating was used. Furthermore, the educa-
tion level of the parents seems to be unrepresentative high 
may have had a positive influence on the treatment outcomes.
Therefore, no firm conclusions about effectiveness of the 
Tackle your Tics program on tics and other symptoms can be 
drawn. The results of the ANOVAs and the non parametrical 
tests showed same results on the outcomes tic severity and 
quality of life (which can be considered as strengthening our 
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conclusions), with one exception: after Bonferroni correc-
tion, the results on tic severity, with non parametrical testing, 
became non significant (p = 0.050). However, the Bonferroni 
correction can be considered as too conservative. Future stud-
ies with larger sample sizes, using a control group are needed.
Conclusion
The present study provides first insight in possibilities to 
offer a brief, intensive and comprehensive therapy group 
program. It suggests that Tackle your Tics is a feasible and 
promising program for children with chronic tic disorders, 
to improve both tic severity as well as quality of life.
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Appendix 1
See Table 4.
Table 4  Treatment satisfaction scores on a 1–5 scale questionnaire (N = 13)
This table shows the answers on the general 5-point Likert scale questions (1 = very negative/not helpful at all; 5 = very positive/helpful)
*Questions with other response categories that have been converted to a 5-point scale
Mean Range SD
Children questionnaire
 General questions (1–5 points scale):
  Q1: What did you think of the number of days?* 4.38 3–5 0.961
  Q2: Was the training as you expected? 3.92 3–5 0.760
  Q3: Did you understand everything well? 4.31 3–5 0.751
  Q5: Have your tics been reduced? 3.08 1–5 1.038
  Q10: What rating would you give the entire week?* 4.31 3–5 0.630
  Q11: Would you recommend this therapy week to other children with tics? 4.77 4–5 0.515
Parents questionnaire
 General questions (1–5 points scale):
  Q1: How helpful was this week for your child? 4.23 2–5 1.013
  Q15: Was the therapy and the explanation you received about it well understood? 4.31 4–5 0.480
  Q16: Have you received enough tools to help your child practice, even after the therapy? 3.77 3–4 0.439
  Q21: Did this message (tics can be controlled but are not wrong) come across sufficiently? 3.85 1–5 0.987
  Q23: What did you think of the extent to which you were involved as a parent in the therapy week?* 4.15 2–5 1.345
  Q24: Are you satisfied with this form of treatment? 4.15 2–5 0.899
  Q25: Would you recommend this intensive form to other parents of children with tics? 4.23 2–5 0.832
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Appendix 2
See Table 5.
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